Journal of Translational Medicine

Table 1 Analysis of immunophenotype

From: Logistics of an advanced therapy medicinal product during COVID-19 pandemic in Italy: successful delivery of mesenchymal stromal cells in dry ice

%	NL₂				Dry ice
%	Batch 1	Batch 2	Batch 3	Mean ± SD	Batch 1	Batch 2	Batch 3	Mean ± SD
7AAD−	95.5	95.2	95.3	95.3 ± 0.2	95.4	93.1	96.6	95.0 ± 1.8
CD105+	99.9	99.7	99.9	99.8 ± 0.1	99.7	99.8	99.8	99.8 ± 0.1
CD90+	99.7	99.7	99.8	99.7 ± 0.1	99.8	99.7	99.6	99.7 ± 0.1
CD73+	100.0	100.0	100.0	100.0 ± 0.0	100.0	100.0	100.0	100.0 ≤ 0.0
CD45+	≤ 2	≤ 2	≤ 2	≤ 2	≤ 2	≤ 2	≤ 2	≤ 2
CD31+	≤ 2	≤ 2	≤ 2	≤ 2	≤ 2	≤ 2	≤ 2	≤ 2
CD34+	≤ 2	≤ 2	≤ 2	≤ 2	≤ 2	≤ 2	≤ 2	≤ 2
HLA DR+	≤ 2	≤ 2	≤ 2	≤ 2	≤ 2	≤ 2	≤ 2	≤ 2

Antigen expression of UC-MSCs transferred from LN₂ to 37 °C (left) and from dry ice to 37 °C (right). No significant differences were demonstrated

Back to article page

ISSN: 1479-5876

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com